Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Hospital Formulary|February 1, 1995
How a CQI program improved aminoglycoside use in a community hospitalW E Wade, C Y McCallPharmacotherapy|March 1, 1995
Pharmacist-managed aminoglycoside therapy in combination with a beta-lactam agent in the treatment of nosocomial pneumonia in critically ill patientsW E Wade, C Y McCallHospital Formulary|October 1, 1990
Drug usage evaluation of aminoglycoside-induced nephrotoxicity in a community hospitalW E Wade, C Y McCallClinical Therapeutics|September 1, 1995
Pharmacoeconomic impact of a drug use evaluation of ceftriaxone in an acute-care medical centerW E Wade, C Y McCallTherapeutic Drug Monitoring|January 1, 1990
Therapeutic drug monitoring in a community hospitalW E Wade, C Y McCallHospital Formulary|September 1, 1994
Educational effort and CQI program improves ordering of serum digoxin levelsW E Wade, C Y McCallTherapeutic Drug Monitoring|November 1, 1989
The use of aerosolized tobramycin in the treatment of a resistant pseudomonal pneumonitisC Y McCall, W J Spruill, W E WadeHeart & Lung : the Journal of Critical Care|May 1, 1994
Aminoglycoside dosing in the critical care patient: a case report of tertiary pharmaceutical careW E Wade, C Y McCall, D W TysonAmerican Journal of Orthopedics (Belle Mead, N.J.)|April 29, 1999
Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgeryW E WadeClinical Therapeutics|May 20, 1998
Cost analysis of ardeparin versus enoxaparin for the prophylaxis of deep vein thrombosis after knee arthroplastyW E WadePageof 3